LOX and metastatic malignant neoplasm in the lymph nodes: LOX expression was associated with lymph node metastasis, distant tumor metastasis, and poor prognosis in GC patients, and the integrated analysis supported LOX as a specific diagnostic and prognostic biomarker for GC patients (Jia et al., 2022).